Editas Medicine (EDIT) Invested Capital (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Invested Capital data on file, last reported at $85.9 million in Q4 2025.

• Invested Capital for Q4 2025 came in at $85.9 million, down 55.2% year-over-year; the trailing twelve-month figure through Dec 2025 was $85.9 million (down 55.2% YoY), and the FY2025 annual result was $85.9 million, down 55.2% from the prior year.
• Invested Capital rose to $85.9 million in Q4 2025 per EDIT's latest filing, from $72.5 million in the prior quarter.
• Over five years, Invested Capital peaked at $638.0 million in Q1 2021 and troughed at $72.5 million in Q3 2025.
• A 5-year average of $340.9 million and a median of $354.8 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2021 and 2025: Invested Capital jumped 171.99% in 2021, then plunged 67.3% in 2025.
• A 5-year view of Invested Capital shows it stood at $553.6 million in 2021, then slumped by 34.85% to $360.7 million in 2022, then declined by 3.21% to $349.1 million in 2023, then slumped by 45.08% to $191.7 million in 2024, then plunged by 55.2% to $85.9 million in 2025.
• Business Quant data shows EDIT's Invested Capital at $85.9 million in Q4 2025, $72.5 million in Q3 2025, and $75.9 million in Q2 2025.